Posts

Showing posts with the label Scaffold Technology Market Size

Scaffold Technology Market Is Expected To Reach $ 2.1 Billion By 2028

  San Francisco, 21 May 2021:   The Report  Scaffold Technology Market  Size, Share & Trends Analysis Report By Type, By Application (Stem Cell, Regenerative Medicine, Drug Discovery), By Disease Type (Cancer, Dental, Neurology), By End-use, And Segment Forecasts, 2021 - 2028 The global scaffold technology market size is expected to reach USD 2.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.4% from 2021 to 2028. The market growth can be primarily attributed to the growing popularity of bioprinting for mimicking the tissue microenvironment in printed 3D tissue models. The need to expand the horizon of multidisciplinary research areas has supplemented the adoption of scaffold technologies in 3D printed models. For instance, in October 2021, researchers integrated novel biomaterial scaffold-guided regeneration for multiple periodontal tissues. The incorporation of advanced imaging modalities along with 3D print

Scaffold Technology Market Is Anticipated To Reach USD 1.5 Billion By 2024: Grand View Research Inc.

San Francisco, 23 May 2019:  The Report  Scaffold Technology Market  Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2018 To 2024 The global Scaffold Technology Market is anticipated to reach USD 1.5 billion by 2024, according to a new report by Grand View Research, Inc.Evolution of scaffold technology, which facilitates the transplantation process, has created opportunities to address tissue engineering-associated challenges such as vascularization. Also, scaffolds are used in the treatment of damaged and diseased organs or tissues to provide support to implants that are surgically inserted into the patient’s body. This is expected to further support the emergence of this vertical. Rise in the aging population and the number of organ defunctionalization cases coupled with the demand for effective treatments are some of the factors promoting the adoption of scaf